Figure 3
Figure 3. Strong expression of CT antigens in extramedullary myeloma using immunohistochemistry. Immunohistochemical staining of an extramedullary plasmocytoma (patient BMT47) with mAb M3H67 to MAGEA3 (A), mAb 57Bm to MAGEA4 (B), mAb E978 to NY-ESO-1 (C), and mAb CT10#5 to MAGE-C2/CT10 (D), diaminobenzidine chromogen. Primarily cytoplasmic expression of MAGEA3 and MAGEA4 in all tumor cells (A, B), mixed cytoplasmic and nuclear presence of NY-ESO-1 in a majority of plasmocytoma cells, and nuclear expression of CT10/MAGEC2 in single tumor cells.

Strong expression of CT antigens in extramedullary myeloma using immunohistochemistry. Immunohistochemical staining of an extramedullary plasmocytoma (patient BMT47) with mAb M3H67 to MAGEA3 (A), mAb 57Bm to MAGEA4 (B), mAb E978 to NY-ESO-1 (C), and mAb CT10#5 to MAGE-C2/CT10 (D), diaminobenzidine chromogen. Primarily cytoplasmic expression of MAGEA3 and MAGEA4 in all tumor cells (A, B), mixed cytoplasmic and nuclear presence of NY-ESO-1 in a majority of plasmocytoma cells, and nuclear expression of CT10/MAGEC2 in single tumor cells.

Close Modal

or Create an Account

Close Modal
Close Modal